Document is current
Any future updates will be listed below
-
Authors
Albach, Fredrik N. https://orcid.org/0000-0002-2697-9080
Geier, Christian https://orcid.org/0000-0001-5281-8187
Keicher, Christian https://orcid.org/0000-0002-7552-4082
Posch, Maximilian G. https://orcid.org/0009-0002-7315-9752
Schreiber, Stephan J. https://orcid.org/0000-0003-4251-6067
Grütz, Gerald https://orcid.org/0000-0003-4003-8639
Akyüz, Levent https://orcid.org/0000-0003-1093-8505
Luo, Xiaodong https://orcid.org/0000-0002-8214-9874
Le-Halpere, Annaig https://orcid.org/0000-0002-9937-9916
Truffinet, Philippe https://orcid.org/0000-0002-5895-9981
Wagner, Frank
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 15 May 2024
Accepted: 22 August 2024
First Online: 9 September 2024
Declarations
:
: The current affiliation for Fredrik N. Albach is: Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany. The current affiliation for Maximilian G. Posch is: Scirent Clinical Research and Science GmbH, Berlin, Germany. Gerald Grütz and Levent Akyüz are employees of Berlin Institute of Health/Charité Universitätsmedizin Berlin and are co-founders of CheckImmune GmbH. Xiaodong Luo, Annaig Le-Halpere, and Philippe Truffinet are employees of Sanofi and may hold shares and/or stock options in the company. Fredrik N. Albach, Christian Geier, Christian Keicher, Maximilian G. Posch, Stephan J. Schreiber, and Frank Wagner have no financial disclosures.
: These trials were conducted in accordance with international ethics guidelines, including the Declaration of Helsinki and International Council for Harmonisation Good Clinical Practice guidelines, and all applicable laws, rules, and regulations. Written informed consent was obtained from all participants.
